Yoshiro Otsuki

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 10

Top Topics

Endometrial Cancer

Estrogen Receptor

Top Venues

Healthcare (Basel, Switzerland)

Current oncology (Toronto, Ont.)

Virchows Archiv : an international journal of pathology

This page only lists publications with an associated author ORCID identifier.

Publications

Yoshiro Otsuki, Yuki Asano, Tomonari Ikeya, Yuki Ishida, Shota Sezaki, Hiroshi Kobayashi
A morphological and immunohistochemical study of ductal carcinoma in situ, invasive breast carcinoma of no special type, and mucinous carcinoma of the breast in comparison with solid papillary carcinoma regarding neuroendocrine marker expression. Virchows Archiv : an international journal of pathology (2024)
Yoshiro Otsuki, Kaori Suwa, Shunsuke Ohtsuka, Natsuko Mori, Masayuki Yoshida, Atsushi Serizawa, Shin-Ichi Shimizu, Hiroshi Kobayashi
A large-scale clinicopathological and long-term follow-up study of solid papillary carcinoma of the breast. Virchows Archiv : an international journal of pathology (2023)
Kiyoka Sawada, Kentaro Nakayama, Sultana Razia, Hitomi Yamashita, Tomoka Ishibashi, Masako Ishikawa, Kosuke Kanno, Seiya Sato, Satoru Nakayama, Yoshiro Otsuki, Satoru Kyo
Promising Therapeutic Impact of Immune Checkpoint Inhibitors in Type II Endometrial Cancer Patients with Deficient Mismatch Repair Status. Healthcare (Basel, Switzerland) 11 (8) (2023)
Kiyoka Sawada, Kentaro Nakayama, Sultana Razia, Hitomi Yamashita, Tomoka Ishibashi, Masako Ishikawa, Kosuke Kanno, Seiya Sato, Satoru Nakayama, Yoshiro Otsuki, Satoru Kyo
Promising Therapeutic Impact of Immune Checkpoint Inhibitors in Type II Endometrial Cancer Patients with Deficient Mismatch Repair Status. Healthcare (Basel, Switzerland) 11 (8) (2023)
Kamrunnahar Shanta, Kentaro Nakayama, Mohammad Mahmud Hossain, Sultana Razia, Tomoka Ishibashi, Masako Ishikawa, Hitomi Yamashita, Kosuke Kanno, Seiya Sato, Satoru Nakayama, Yoshiro Otsuki, Satoru Kyo
Promising Therapeutic Impact of a Selective Estrogen Receptor Downregulator, Fulvestrant, as Demonstrated In Vitro upon Low-Grade Serous Ovarian Carcinoma Cell Lines. Current oncology (Toronto, Ont.) 29 (6) (2022)
Hiroki Sasamori, Kentaro Nakayama, Sultana Razia, Hitomi Yamashita, Tomoka Ishibashi, Masako Ishikawa, Seiya Sato, Satoru Nakayama, Yoshiro Otsuki, Ritsuto Fujiwaki, Noriyoshi Ishikawa, Satoru Kyo
Mutation Profiles of Ovarian Seromucinous Borderline Tumors in Japanese Patients. Current oncology (Toronto, Ont.) 29 (5) (2022)
Yuki Nonomura, Kentaro Nakayama, Kohei Nakamura, Sultana Razia, Hitomi Yamashita, Tomoka Ishibashi, Masako Ishikawa, Seiya Sato, Satoru Nakayama, Yoshiro Otsuki, Satoru Kyo
Ovarian Endometrioid and Clear Cell Carcinomas with Low Prevalence of Microsatellite Instability: A Unique Subset of Ovarian Carcinomas Could Benefit from Combination Therapy with Immune Checkpoint Inhibitors and Other Anticancer Agents. Healthcare (Basel, Switzerland) 10 (4) (2022)
Keisuke Hatano, Ayataka Fujimoto, Chikanori Inenaga, Yoshiro Otsuki, Hideo Enoki, Tohru Okanishi
Non-Ruptured Temporal Lobe Dermoid Cyst Concomitant with Focal Cortical Dysplasia Causing Temporal Lobe Epilepsy-A Case Report and Literature Review. Brain sciences 11 (9) (2021)
Tomoka Ishibashi, Kentaro Nakayama, Sultana Razia, Masako Ishikawa, Kohei Nakamura, Hitomi Yamashita, Puja Dey, Koji Iida, Hiroko Kurioka, Satoru Nakayama, Yoshiro Otsuki, Noriyoshi Ishikawa, Satoru Kyo
High Frequency of PIK3CA Mutations in Low-Grade Serous Ovarian Carcinomas of Japanese Patients. Diagnostics (Basel, Switzerland) 10 (1) (2019)
Yoshihiko Tomita, Peter Schraml, Silvia Angori, Aashil A Batavia, Niels J Rupp, Chisato Ohe, Yoshiro Otsuki, Takashi Kawasaki, Hiroshi Kobayashi, Kazuhiro Kobayashi, Tatsuhiko Miyazaki, Hiroyuki Shibuya, Hiroyuki Usuda, Hajime Umezu, Fumiyoshi Fujishima, Bungo Furusato, Mitsumasa Osakabe, Tamotsu Sugai, Naoto Kuroda, Toyonori Tsuzuki, Yoji Nagashima, Yoichi Ajioka, Holger Moch
Classic Chromophobe Renal Cell Carcinoma Incur a Larger Number of Chromosomal Losses Than Seen in the Eosinophilic Subtype. Cancers 11 (10) (2019)